Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

AGM Statement

31 Jul 2008 07:00

RNS Number : 2540A
Halma PLC
31 July 2008
 



HALMA p.l.c.

AGM Trading Update / Interim Management Statement

31 July 2008

Halma, the leading safety, health and sensor technology group, is holding its 114th AGM later today, at which Geoff Unwin, Chairman, will make the following statement. This announcement comprises the Group's Interim Management Statement relating to the period 30 March - 31 July 2008 and includes the first quarter's trading.

"Revenue and order intake for the first quarter of this financial year showed good growth over last year, which is in line with the Board's expectations.

"Underlying organic growth in all three Halma sectors (Infrastructure Sensors, Health & Analysis and Industrial Safety) was boosted further by a positive impact from currency movements of approximately 3%. In addition, Riester, the German medical instrumentation business acquired in December 2007, has performed well.

"We continue to see opportunities for sustained growth in our existing markets both organically and via acquisitions. This reflects our successful strategy of operating in diverse markets underpinned by resilient growth drivers such as the demand for energy and water resources, increasing demand for healthcare, rising expectations of health and safety and long term demographic trends.

"Our investment in building our business in developing markets continues. The new Halma 'hub' in Mumbai will be operational in October 2008 providing an important platform for more of our businesses to grow their commercial and technical presence in India. In Shanghai, the Halma manufacturing hub will be ready for occupancy in October 2008, enabling four more businesses to establish local product assembly and procurement in the Chinese market. Over the medium term, we expect the demand for our safety, health and environmentally related products to increase in both of these key territories.

"The Group's financial position continues to be strong and there have been no material events or transactions affecting the Group.

"As stated at the time of our year end results in June, the Board believes that Halma is well positioned to make further progress in the current year and beyond."

For further information, please contact:

Halma p.l.c.

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

Tel: +44 (0)1494 721111

Hogarth Partnership Limited 

Rachel Hirst/Andrew Jaques

Tel: +44 (0)20 7357 9477

Notes:

1.

The half-yearly results for the period to 27 September 2008 are expected to be released on 27 November 2008.

2.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

3.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFKKKQPBKDPON
Date   Source Headline
15th Oct 20211:06 pmRNSDirector/PDMR Shareholding
4th Oct 20212:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:01 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading update
9th Sep 202110:22 amRNSDirector Declaration
9th Aug 20217:00 amRNSM&A Update
26th Jul 202111:01 amRNSDirector/PDMR Shareholding
22nd Jul 20213:00 pmRNSResult of AGM
5th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jun 20211:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:47 pmRNSAnnual Financial Report
10th Jun 20217:01 amRNSUnaudited restated segmental information
10th Jun 20217:00 amRNSFull Year Results 2021
27th Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSAppointment of independent non-executive Director
24th Mar 20217:00 amRNSTrading update
23rd Feb 20217:54 amRNSDirector Declaration
10th Feb 20214:52 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSDirectorate Change
21st Dec 20202:00 pmRNSAcquisition
18th Dec 20207:00 amRNSDisposal
4th Dec 20207:04 amRNSDirector Declaration
2nd Dec 20204:08 pmRNSDirector/PDMR Shareholding
25th Nov 20203:20 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSHALF YEAR RESULTS 2020/21
5th Oct 20201:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:05 amRNSDirector Declaration
23rd Sep 20207:00 amRNSChair retirement
23rd Sep 20207:00 amRNSTrading update
4th Sep 20204:57 pmRNSResult of AGM
31st Jul 20204:06 pmRNSDirector/PDMR Shareholding
24th Jul 20205:02 pmRNSAnnual Financial Report
17th Jul 20209:32 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSFinal Results
15th May 20201:29 pmRNSElectronic Communications with Shareholders
27th Apr 202012:46 pmRNSDisclosure of Rights Attached to Equity Shares
21st Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20207:05 amRNSExecutive Board changes
19th Mar 20207:00 amRNSTrading Statement
5th Mar 20209:00 amRNSInvestor Event
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSAcquisition
5th Feb 20207:00 amRNSAcquisition
27th Jan 20207:00 amRNSAcquisition
22nd Jan 202012:58 pmRNSChange of Remuneration Committee Chair
29th Nov 20191:27 pmRNSDirector/PDMR Shareholding
25th Nov 20195:10 pmRNSDirector/PDMR Shareholding
19th Nov 201911:45 amRNSDividend Declaration
19th Nov 20197:00 amRNSHalf-year Report
2nd Oct 20195:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.